We are live on ! Find out more
WCG

Wellcare Health Plans, Inc.
WCG

Delisted

WCG was delisted on the 23rd of January, 2020.

323 hedge funds and large institutions have $7.91B invested in Wellcare Health Plans, Inc. in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 119 increasing their positions, 139 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more capital invested

Capital invested by funds: $6.22B → $7.91B (+$1.69B)

3% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 29

1% less funds holding

Funds holding: 327323 (-4)

14% less repeat investments, than reductions

Existing positions increased: 119 | Existing positions reduced: 139

35% less call options, than puts

Call options by funds: $39.3M | Put options by funds: $60.6M

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

Holders
323
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
8.05%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
28
Increased
119
Reduced
139
Closed
29
Calls
$39.3M
Puts
$60.6M
Net Calls
-$21.3M
Net Calls Change
-$12.2M
Name Holding Trade Value Shares
Change
Change in
Stake
KBC Group
251
KBC Group
Belgium
$397K -$103K -619 -22%
Nomura Holdings
252
Nomura Holdings
Japan
$382K -$239K -1,441 -40%
Stifel Financial
253
Stifel Financial
Missouri
$379K -$166K -1,004 -33%
M&T Bank
254
M&T Bank
New York
$376K +$994 +6 +0.3%
LA
255
Lucus Advisors
New York
$359K -$156K -942 -32%
MCM
256
MAI Capital Management
Ohio
$359K
VKH
257
Virtu KCG Holdings
New York
$339K -$909K -5,487 -74%
LPL Financial
258
LPL Financial
California
$339K +$313K +1,886 New
Cambridge Investment Research Advisors
259
Cambridge Investment Research Advisors
Iowa
$338K +$55.5K +335 +22%
NIT
260
NumerixS Investment Technologies
British Columbia, Canada
$323K +$82.9K +500 +38%
HIM
261
Hillsdale Investment Management
Ontario, Canada
$312K +$275K +1,660 +2,075%
NFP
262
Narus Financial Partners
Utah
$307K -$4.31K -26 -1%
BCM
263
Bayesian Capital Management
New York
$307K +$284K +1,711 New
Zurich Cantonal Bank
264
Zurich Cantonal Bank
Switzerland
$298K +$30.5K +184 +12%
BRWA
265
B. Riley Wealth Advisors
Florida
$291K -$5.63K -34 -2%
CG
266
Cutler Group
California
$287K -$959K -5,786 -78%
Credit Agricole
267
Credit Agricole
France
$287K -$376K -2,272 -59%
ZDA
268
Zweig-DiMenna Associates
New York
$287K +$265K +1,600 New
Calamos Advisors
269
Calamos Advisors
Illinois
$280K
NA
270
Navellier & Associates
Nevada
$274K -$27K -163 -10%
CCIA
271
Campbell & Co Investment Adviser
Maryland
$271K +$250K +1,510 New
SSP
272
Sapphire Star Partners
Washington
$269K -$31.3K -189 -11%
GCA
273
Gideon Capital Advisors
New York
$268K -$126K -760 -34%
HSBC Holdings
274
HSBC Holdings
United Kingdom
$267K -$1.35M -8,158 -85%
Wolverine Trading
275
Wolverine Trading
Illinois
$266K +$246K +1,487 New

WCG Hedge Fund Activity: Q2 2017 in Review

323 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Wellcare Health Plans, Inc. (WCG) for Q2 2017, worth a combined $7.91B — up 27% from $6.22B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of WCG and 28 opened new positions — a net loss of 1 holder — while 139 trimmed existing stakes and 119 added.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $157M. The largest seller was T. Rowe Price Associates, cutting an estimated $43.7M.

  • 323 institutional investors held Wellcare Health Plans, Inc. (WCG) as of Q2 2017, down from 327 in Q1 2017.
  • Funds reported $7.91B of Wellcare Health Plans, Inc. stock for Q2 2017, up 27% quarter-over-quarter.
  • 28 funds opened new Wellcare Health Plans, Inc. positions in Q2 2017 and 29 closed out, a net change of -1 holder.
  • The largest Wellcare Health Plans, Inc. buyer in Q2 2017 was Capital Research Global Investors, an estimated $157M added.
  • The largest Wellcare Health Plans, Inc. seller in Q2 2017 was T. Rowe Price Associates, an estimated $43.7M sold.

Based on aggregated 13F filings for Q2 2017.